St. Antonius Hospital Gronau
6
1
1
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Tumor Rupture During Robotic Partial Nephrectomy
Role: collaborator
EFFICACY of INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION on the POSTOPERATIVE BLOOD LOSS in PATIENTS UNDERGOING RARP for the TREATMENT of PROSTATE CANCER
Role: lead
Postoperative Patient Comfort and Quality of Micturition in Suprapubic Tube vs. Transurethral Catheterization After RARP
Role: lead
Detection of Lymphnodes Using ICG During RARP
Role: lead
Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical Prostatovesiculectomy
Role: collaborator
Prospective Randomized Trial Comparing Urinary Diversion After Robot-assisted Radical Prostatectomy
Role: lead
All 6 trials loaded